News Suven Pharmaceuticals Limited

Equities

SUVENPHAR

INE03QK01018

End-of-day quote NSE India S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
645.6 ^INR	-2.34%		-3.58%	-10.67%

27/03	Suven Pharmaceuticals Limited Announces Shifting of Registered Office	CI
05/03	Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Suven Pharmaceuticals Limited Announces Shifting of Registered Office	27/03	CI
Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call	05/03
Indian shares set to rise on strong domestic growth, in-line US inflation data	01/03	RE
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million	29/02	CI
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India	23/02	MT
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3	06/02	MT
Transcript : Suven Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 05, 2024	05/02
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02	CI
Suven Pharmaceuticals CFO Steps Down	26/12	MT
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024	22/12	CI
Suven Pharmaceuticals Names CFO	22/12	MT
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director	15/12	CI
Suven Pharmaceuticals Limited Announces Board Appointments	15/12	CI
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24	15/12	CI
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23	22/11	CI
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit	14/11	MT
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Transcript : Suven Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023	09/11
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.	03/11	CI
Suven Pharmaceuticals Limited Announces Board Changes	29/23/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Suven Pharmaceuticals Limited

Equities

SUVENPHAR

INE03QK01018

Summary

Filters